Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 37.17 is 72% above its 3-year average of 21.63, around the middle of its 3-year range (0.00–58.92).
As of the fiscal period ended Tuesday, June 30, 2026. 18.95% above its 12-month average of 31.25.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.17.
QUICK RATIO (ACID-TEST)
37.17
QUICK RATIO (ACID-TEST) AVG TTM
31.25
QUICK RATIO (ACID-TEST) AVG 3Y
27.34
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.95%
CURRENT VS 3Y AVG
+35.97%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
+1143.19%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$484.56M
Quick Ratio (Acid-Test)
37.17
TTM Avg
31.25
3Y Avg
27.34
5Y Avg
N/A
Market Cap
$483.26M
Quick Ratio (Acid-Test)
7.91
TTM Avg
4.78
3Y Avg
4.69
5Y Avg
6.49
Market Cap
$477.61M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$488.09M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$514.16M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$458.01M
Quick Ratio (Acid-Test)
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $484.56M | 37.17 | 31.25 | 27.34 | N/A |
| Arvinas, Inc. (ARVN)vs › | $483.26M | 7.91 | 4.78 | 4.69 | 6.49 |
| Cerus Corporation (CERS)vs › | $477.61M | 1.07 | 1.48 | 1.43 | 1.74 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $488.09M | 121.97 | 23.71 | 19.95 | 19.50 |
| NRC Health (NRC)vs › | $470.12M | 0.65 | 0.55 | 0.77 | 1.10 |
| NeoGenomics, Inc. (NEO)vs › | $514.16M | 3.35 | 2.92 | 4.56 | 5.25 |
| Evolus, Inc. (EOLS)vs › | $491.93M | 1.28 | 1.88 | 1.90 | 1.89 |
| Kamada Ltd. (KMDA)vs › | $465.02M | 2.29 | 2.21 | 1.73 | 2.24 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $458.01M | 6.72 | 10.04 | 13.74 | 16.43 |
| Assembly Biosciences, Inc. (ASMB)vs › | $452.63M | 13.99 | 3.82 | 4.27 | 5.98 |
Quick Ratio
37.17
Excludes inventory
Current Ratio
37.17
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 37.17 |
| 2026-03-31 | 38.00 |
| 2025-12-31 | 27.50 |
| 2025-09-30 | 29.07 |
| 2025-06-30 | 24.51 |
| 2025-03-31 | 21.47 |
| 2024-12-31 | 20.69 |
| 2024-09-30 | 37.06 |
| 2024-06-30 | 58.92 |
| 2024-03-31 | 19.20 |
| 2023-12-31 | 23.29 |
| 2023-09-30 | 18.50 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 6.41 |
